Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kroopa Joshi

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
JCO Precision Oncology|April 16, 2025
Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical TrialsRafael Grochot, Kroopa Joshi, Antonella Cammarota, et al.
Nature Communications|November 4, 2018
Author Correction: Pan-cancer deconvolution of tumour composition using DNA methylationAnkur Chakravarthy, Andrew Furness, Kroopa Joshi, et al.
Frontiers in Immunology|October 28, 2017
Quantitative Characterization of the T Cell Receptor Repertoire of Naïve and Memory Subsets Using an Integrated Experimental and Computational Pipeline Which Is Robust, Economical, and VersatileTheres Oakes, James M Heather, Katharine Best, et al.
Nature Communications|August 15, 2018
Pan-cancer deconvolution of tumour composition using DNA methylationAnkur Chakravarthy, Andrew Furness, Kroopa Joshi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2020
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancerVasileios Angelis, Zayd Tippu, Kroopa Joshi, et al.
The Journal of Experimental Medicine|September 28, 2018
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironmentYien Ning Sophia Wong, Kroopa Joshi, Pramit Khetrapal, et al.
Nature|March 22, 2019
Neoantigen-directed immune escape in lung cancer evolutionRachel Rosenthal, Elizabeth Larose Cadieux, Roberto Salgado, et al.
Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
Immunity|April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established TumorsFrederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Nature Medicine|June 5, 2020
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancerKroopa Joshi, Marc Robert de Massy, Mazlina Ismail, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
JCO Precision Oncology|April 16, 2025
Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical TrialsRafael Grochot, Kroopa Joshi, Antonella Cammarota, et al.
Nature Communications|November 4, 2018
Author Correction: Pan-cancer deconvolution of tumour composition using DNA methylationAnkur Chakravarthy, Andrew Furness, Kroopa Joshi, et al.
Frontiers in Immunology|October 28, 2017
Quantitative Characterization of the T Cell Receptor Repertoire of Naïve and Memory Subsets Using an Integrated Experimental and Computational Pipeline Which Is Robust, Economical, and VersatileTheres Oakes, James M Heather, Katharine Best, et al.
Nature Communications|August 15, 2018
Pan-cancer deconvolution of tumour composition using DNA methylationAnkur Chakravarthy, Andrew Furness, Kroopa Joshi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2020
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancerVasileios Angelis, Zayd Tippu, Kroopa Joshi, et al.
The Journal of Experimental Medicine|September 28, 2018
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironmentYien Ning Sophia Wong, Kroopa Joshi, Pramit Khetrapal, et al.
Nature|March 22, 2019
Neoantigen-directed immune escape in lung cancer evolutionRachel Rosenthal, Elizabeth Larose Cadieux, Roberto Salgado, et al.
Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
Immunity|April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established TumorsFrederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Nature Medicine|June 5, 2020
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancerKroopa Joshi, Marc Robert de Massy, Mazlina Ismail, et al.
Pageof 3